Apricus Biosciences, Inc. APRI
— —
Regular-session close
Day range unavailable
52-week range unavailable
News
seekingalpha.com Aprinoia Therapeutics Starts $50 Million IPO For Neurodegenerative Disease Treatments Aprinoia Therapeutics has filed for a $50 million IPO to develop diagnostics and therapeutics for neurodegenerative diseases. The company's lead therapeutic candidate is in Phase 1a trials for…
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018 
benzinga.com Earnings Scheduled For March 17, 2014